Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding
author
Päll, Taavi
Gad, A.
Kasak, L.
Drews, Monika
Strömblad, Sraffan
Kogerman, Priit
statement of authorship
T.Päll, A.Gad, L.Kasak, M.Drews, S.Strömblad, P.Kogerman
source
Oncogene
journal volume number month
23
year of publication
2004
pages
47, p. 7874-7881
url
https://www.nature.com/articles/1208083
subject term
angiogenees
hüaluroonhape
inhibiitorid
vähk (meditsiin)
kasvajarakud
language
inglise